A detailed history of Dearborn Partners LLC transactions in Insulet Corp stock. As of the latest transaction made, Dearborn Partners LLC holds 1,000 shares of PODD stock, worth $232,750. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,000
Holding current value
$232,750
% of portfolio
0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 26, 2024

BUY
$161.02 - $206.98 $161,020 - $206,980
1,000 New
1,000 $201,000
Q4 2023

Jan 26, 2024

BUY
$127.77 - $221.42 $127,770 - $221,420
1,000 New
1,000 $216,000
Q3 2022

Oct 25, 2022

BUY
$224.6 - $281.45 $224,600 - $281,450
1,000 New
1,000 $229,000
Q3 2020

Oct 20, 2020

BUY
$192.55 - $236.59 $192,550 - $236,590
1,000 New
1,000 $237,000

Others Institutions Holding PODD

About INSULET CORP


  • Ticker PODD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 69,403,600
  • Market Cap $16.2B
  • Description
  • Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sel...
More about PODD
Track This Portfolio

Track Dearborn Partners LLC Portfolio

Follow Dearborn Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dearborn Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dearborn Partners LLC with notifications on news.